Concepedia

Anna Kan

AK

28

Publications

1.2K

Citations

19

H-Index

2014

Active since

Affiliations

Sun Yat-sen University(Current)

Sun Yat-sen University Cancer Center

State Key Laboratory of Oncology in South China

Shantou University

Shanghai Medical College of Fudan University

Anna Kan is an author at Sun Yat-sen University specializing in medicine, radiation oncology, and cancer therapeutics.

ORCID

Top concepts

Publications per year

2014–2024

28

Publications

28

Dual Vascular Endothelial Growth Factor Receptor and Fibroblast Growth Factor Receptor Inhibition Elicits Antitumor Immunity and Enhances Programmed Cell Death-1 Checkpoint Blockade in Hepatocellular Carcinoma

Haijing Deng, Anna Kan, Ning Lyu et al. · Liver Cancer · 2020 · 171 citations · Full text

Tumor-derived lactate inhibit the efficacy of lenvatinib through regulating PD-L1 expression on neutrophil in hepatocellular carcinoma

Haijing Deng, Anna Kan, Ning Lyu et al. · Journal for ImmunoTherapy of Cancer · 2021 · 156 citations · Full text

Lenvatinib, toripalimab plus hepatic arterial infusion chemotherapy in patients with high-risk advanced hepatocellular carcinoma: A biomolecular exploratory, phase II trial

ZhiCheng Lai, Minke He, Xiaoyun Bu et al. · European Journal of Cancer · 2022 · 141 citations

, , +11

Oxidative stress induces monocyte‐to‐myofibroblast transdifferentiation through p38 in pancreatic ductal adenocarcinoma

Xin Huang, Chaobin He, Xin Hua et al. · Clinical and Translational Medicine · 2020 · 78 citations · Full text

CBX3/HP1γ promotes tumor proliferation and predicts poor survival in hepatocellular carcinoma

Xiaoping Zhong, Anna Kan, Wancong Zhang et al. · Aging · 2019 · 71 citations · Full text

Rows per page

1–5 of 28